Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: Efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
- Antolín, S.
- Acea, B.
- Albaina, L.
- Concha, Á.
- Santiago, P.
- García-Caballero, T.
- Mosquera, J.J.
- Varela, J.R.
- Soler, R.
- Calvo, L.
Revista:
Breast Cancer: Targets and Therapy
ISSN: 1179-1314
Año de publicación: 2019
Volumen: 11
Páginas: 29-42
Tipo: Artículo
